Drug Shortage Report for APO-FENO-SUPER

Last updated on 2021-01-26 History
Report ID 132352
Drug Identification Number 02246860
Brand name APO-FENO-SUPER
Common or Proper name FENO-SUPER
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) FENOFIBRATE
Strength(s) 160MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100 BTL
ATC code C10AB
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-01-18
Estimated end date 2021-01-22
Actual end date 2021-01-25
Shortage status Resolved
Updated date 2021-01-26
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-01-26 French Compare
v3 2021-01-26 English Compare
v2 2021-01-22 French Compare
v1 2021-01-22 English Compare